5:53 PM
 | 
Jul 12, 2012
 |  BC Extra  |  Company News

Affymax jumps on peginesatide supply deal with Fresenius

Affymax Inc. (NASDAQ:AFFY) jumped $2.29 (19%) to $14.24 on Thursday after the biotech and partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) announced a supply agreement for Omontys peginesatide with dialysis services provider Fresenius Medical...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >